Cargando…
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
Cross-reactivity among the two diverse viruses is believed to originate from the concept of antibodies recognizing similar epitopes on the two viral surfaces. Cross-reactive antibody responses have been seen in previous variants of SARS and SARS-CoV-2, but little is known about the cross reactivity...
Autores principales: | Perween, Reshma, PraveenKumar, Murugavelu, Shrivastava, Tripti, Parray, Hilal Ahmed, Singh, Vanshika, Singh, Swarandeep, Chiranjivi, Adarsh, Jakhar, Kamini, Sonar, Sudipta, Tiwari, Mahima, Reema, Panchal, Anil Kumar, Sharma, Chandresh, Rathore, Deepak Kumar, Ahamed, Shubbir, Samal, Sweety, Mani, Shailendra, Bhattacharyya, Sankar, Das, Supratik, Luthra, Kalpana, Kumar, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479463/ https://www.ncbi.nlm.nih.gov/pubmed/34649114 http://dx.doi.org/10.1016/j.intimp.2021.108187 |
Ejemplares similares
-
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
por: Murugavelu, Praveenkumar, et al.
Publicado: (2021) -
Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
por: Parray, Hilal Ahmad, et al.
Publicado: (2021) -
Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
por: Parray, Hilal Ahmad, et al.
Publicado: (2020) -
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
por: Parray, Hilal Ahmed, et al.
Publicado: (2020) -
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
por: Parray, Hilal Ahmad, et al.
Publicado: (2022)